Skip to main content

What the FDA labels say about taking them together

Darifenacin and verapamil

Darifenacin's FDA label of February 10, 2026 names verapamil in its drug interactions section; the verapamil labels PlainMeds reads (4) do not name darifenacin. The darifenacin label: “No dosing adjustments are recommended in the presence of moderate CYP3A4 inhibitors.”

Check it at the source: the darifenacin FDA label on DailyMed (effective February 10, 2026, Torrent Pharmaceuticals Limited); the verapamil FDA label on DailyMed (effective April 6, 2026, Zydus Pharmaceuticals (USA) Inc.).

What does the darifenacin label say about verapamil?

Darifenacin label, drug interactions

No dosing adjustments are recommended in the presence of moderate CYP3A4 inhibitors (for example, erythromycin, fluconazole, diltiazem and verapamil) [see Dosage and Administration (2) and Clinical Pharmacology (12.3)].

Source: FDA drug label (Darifenacin), Torrent Pharmaceuticals Limited, effective February 10, 2026 (SPL set e84f1ae3-b9a2-4a15-a299-c75373891cc1), via openFDA; the full label on DailyMed

What does the verapamil label say about darifenacin?

Verapamil's label (effective April 6, 2026) and its 3 other brand-application labels do not name darifenacin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Verapamil hydrochloride), Zydus Pharmaceuticals (USA) Inc., effective April 6, 2026 (SPL set e19ab8d8-dae5-489d-9805-7e7407bea06d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

8Darifenacin generic labelers
43Verapamil generic labelers
DarifenacinVerapamil
Labeled forOveractive bladderHigh blood pressure, Atrial fibrillation, Angina
Boxed warningNoNo
Pharmacy cost (NADAC)$0.432 per tablet 15 mg tablet$0.191 per tablet 180 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?